Perimetry's reliability indices were fixation loss <33%; false positive <25% and false negative <25%. Standard automated perimetry visual field defects were considered abnormal if the PSD was triggered at the 5%, 2%, 1%, or 0.5% levels.
All patients gave informed consent.
Exclusion criteria: primary angle closure glaucoma, secondary glaucoma, previous complex anterior segment/vitreoretinal procedures, diabetic retinopathy.
RESULTS
The sample size for patients with POAG was n 91 eyes (46 patients) and control was n 92 eyes [46 patients] ( Table 1 ). The data for POAG and controls were: mean age 62 yrs (SD12yrs ) vs 54yrs (SD 13yrs); mean CCT 536um (SD 31.29um) vs 532um (SD 31.96um) p 0.21; family history of glaucoma 25% vs 23%; essential hypertension 17% vs 9%; diabetes mellitus 17% vs 41%.
Notably, 80.2% of POAG and 78.3% of controls had CCT <555um (Fig 1) . Further analysis of the Gaussian curve using 40um incremental decrease in CCT is demonstrated in colour columns. This clearly demonstrates that the majority of patients in both cohorts have 2-4 fold increased risk of developing POAG. Pertinently, it also shows the inherent danger of interpreting the IOP in isolation whereby thin corneas have an underestimation of the IOP. Lalchan 
DISCUSSION
Primary open angle glaucoma (POAG) is the world's leading cause of bilateral irreversible blindness in developing countries (7, 8) . Patients in the Caribbean are amongst the highest risk populations for developing glaucoma with a prevalence of up to 10% compared to 3% in patients of European Descent (1, 2, 9) . Modern glaucoma specialists and diagnostic imaging increase the sensitivity and specificity of glaucoma detection; early diagnosis and treatment can prevent blindness (10, 11) . These benefits need to filter down to developing countries.
Despite modern medicine, up to 90% of patients in developing countries are unaware (12, 13, 14) . The reasons are multi-factorial inclusive of patient factors, professional factors and policy-makers decisions. Patient factors include awareness/education, cultural attitudes, access to professional care and affordability to medications and specialist expertise.
Professional factors include lack of awareness of the magnitude of the problem amongst the general physicians, misconceptions about diagnostics techniques and modern surgical techniques.
Additionally, policy-makers in developing countries tend to focus on cataracts and refractive errors as these have defined end points (9) . There is far less emphasis on glaucoma care as the complexity includes chronicity, high expenditures (both medical and surgical) and skilled long-term professional support. Compounding this is the lack of appreciation of, the clearly defined roles of ophthalmologists in contrast to opticians. Only the former is trained to diagnose and treat any medical illness as defined by NICE (UK) and AAO guidelines and the laws of Trinidad and Tobago. Glaucoma is no exception.
There is no clear evidence to suggest that factors, inclusive of demographics, geography, genetics, cultural, social and/or economics, contribute significantly to poor outcomes in high risk patients (15) . The seminal Ocular Hypertension Treatment Study (OHTS) was a Epidemiology of Central Corneal Thickness in Trinidad and Tobago randomised control trial which identified risk factors for conversion from ocular hypertension to glaucomatous optic neuropathy (GON); statistically significant factors following multivariate analysis were increasing age, large vertical/horizontal cup disc ratio, high intraocular pressure (IOP) and pattern standard deviation (specific measurement on Humphrey's perimetry 24-2 using SITA fast) and central corneal thickness (3) (4) (5) .
Further analysis of the relationship with CCT showed an inverse relationship with the development of POAG (POAG ∞ 1/CCT) ie the lower the CCT the greater the risk of developing POAG without a threshold effect (3) [Fig 1] .
The clinical applications of CCT in glaucoma management are as follows: firstly, for simplicity, if the patients' CCT< 555um, the risk increases 3.4 fold 4 . Secondly, CCT is used in risk calculator measurements to help determine the risk of progression to glaucomatous optic neuropathy (3). Thirdly, corneal surgeries such as penetrating keratoplasty and LASIK (Laserassisted in-situ keratomileusis) modify the IOP parameters. It is important to note that CCT adjusted IOP is no longer applicable as there was no improvement in prediction models 3 .
In this study mean CCT was 536um for patients with POAG vs 532um for controls. This is comparable to other studies; of note the BESS (n 1142) had a CCT 529.8um vs Caucasians
um (16). Epidemiological studies have shown that patients of Caribbean Descent (CD),
African Descent and Japanese have the lowest CCT [ Table 1 ] (17, 18).
Notably, 80.2% of POAG and 78.3% of controls had CCT <555um (Fig 1) . This is important. Firstly, it means approximately 80% of the entire study group, POAG and controls, has a 3.4 fold independent risk of developing POAG. Secondly, the predominance of thin corneas means inherently lower IOP measurements which are at risk of 'underestimation' (Table 2 ). This has several implications:
1) It is important to take a moment to outline the limitations of Goldmann IOP measurement which to date, remains the gold standard (19) . It is based on Imbert-Fick's principle which states Lalchan that the measurement of the internal pressure of a dry, thin walled sphere can be measured by an externally applied force (Fig 2) . Note the cornea is neither thin, dry nor spherical; to reduce the errors the CCT is based on 530um, the tonometer head is 3.06mm 2 to compensate for the surface tension of the tears and measures the very central aspect of the cornea (reducing the peripheral aspheric effect).
CCT and IOP both have an independent effect on the risk of developing GON, but these two factors also interact. When Goldmann applanation tonometry (GAT) was introduced in the 1950s, the thickness of the cornea was recognized as a potential confounder to IOP measurement.
2) CCT measurements are known to affect IOP measurements; if thin, there is an underestimation; if thick there is an overestimation. Of note, patients with diabetes mellitus are often observed to have thick CCT's; but this was the opposite in our study (20) . Additionally,
CCT is known to be a highly heritable trait (21) . There are some who purport CCT is simply a phenotypic variation rather than a true risk factor. Our small gene pool may be reflective of this view.
3) Notably, many patients and non-medical eye care providers also believe that diagnosing glaucoma is simply 'a pressure check' ie the intraocular pressure. Glaucoma is defined as a heterogeneous group of diseases which results in damage to the nerve fibre layer. IOP is accepted as a risk factor not a defining factor; additionally, there are known IOP and non-IOP dependent factors.
The reason for IOP remaining important is that, to date it is the only modifiable risk factor. It is also well documented globally, that 90% of patients with POAG have IOP
<21mmHg (previously classified as normal tension glaucoma). It is now clear to Epidemiology of Central Corneal Thickness in Trinidad and Tobago
glaucomologists, that each nerve has its individual pressure sensitivity with the realisation that IOP alone is misleading for both diagnosing and monitoring glaucoma.
Therein lays the danger when patients and non-medical eye care providers assume IOP is 'normal'. The situation becomes dire when the IOP is underestimated in the presence of thin CCT applicable for 78% of the control sample (Table 2 ). In fact, BESS in 2007 showed a fourfold greater risk of developing POAG if patients are only monitored by opticians (22) . It also demonstrated that patients have a greater chance of delayed diagnosis if only seen by a non-medic eye care provider, hence the importance of the ophthalmologist in early diagnosis (23) . Other studies reflect this, so much so that, the recommendations are that patients need to be screened by an ophthalmologist. This is also comparable to NICE and AAO guidelines.
4) It is important to note there is no specific single examination or test that confirms glaucoma diagnosis, especially in the very early stages. An IOP measurement alone cannot indicate the absence or presence of the disease. This is an important barrier towards accessing a comprehensive glaucoma diagnostic assessment. Modern diagnosis of early glaucoma includes:
tonometry, pachymetry, gonioscopy stereoscopic optic nerve viewing/photography, perimetry and laser-assisted optic nerve imaging (1, 3) . Often, it is such that the various components have to be considered as pieces of a puzzle, notably with clinical impression at the core of evaluation of modern diagnostics ie 'glaucoma composites' [Fig 3] (24).
It is no different form a formal cardiac, renal or neurological assessments requiring the necessary investigations and expertise.
The second major risk factor identified in this study was family history. The family history rates are high within our population with 25% in POAG group and 23% in control reporting a first/second degree family history. Other studies in high risk patients report similar
rates. The presence of family history independently increases the risk of POAG 10 fold. There are currently three well documented genes ie myocilin, optineurin and WGR. Myocilin the most well know, contribute to only 3% of POAG. Lalchan 7 There is no convincing evidence that DM is a factor for development of POAG. It is well know that DM has thick corneas and some studies have felt DM to be protective of POAG risk. It was quite surprising to the authors to find the opposite in our population. DM patients constituted 41% of controls of which the group demonstrated a comparable mean CCT with 78% have CCT<555um.
Local internal auditing (n 3360) showed a prevalence of 10% n 340, with 26.5% under 50yrs (comparable to international statistics), with 20% presenting with moderate to severe visual field loss. The prevalence is not surprising given the risk factors outlined: 80% thin CCT, 25% family history. However, the severity at presentation is disappointing. More needs to be done; more can be done:
1 Public awareness campaigns will improve education and awareness;
2 Affordability of medications on CDAP will mean better access to modern treatment;
3 Targeted training for ophthalmic surgeons in the public sector 4 Adoption of internal auditing to ensure safe outcomes for patients 5 A national glaucoma screening programme-Consultant-led (this is challenging as to date there is no established programme globally. There are some pilots with very good results.
6 The realisation by all, policy-makers, the university, medical professionals and patients, that early diagnosis requires an ophthalmologist not an optician.
This study adds to the body of evidence that we have the highest risk; equally important to note is, more needs to be done. On the shop floor patients, non-medical professional and general practitioners need to be more aware of the precise components necessary to diagnosis glaucoma early to reduce blindness rates. Policy makers need to take a more active role in public education and improving the affordability of glaucoma medications.
These patients continue to go blind silently. The time to effect change has always been now. Fig 1: Gaussian curve plot of the range of CCT for both POAG and controls groups. Two salient features include, firstly, the majority of patients had a CCT of <555um. Secondly, using 40um incremental decrease in CCT indicates the majority of patients have a 2-4 fold independent risk factor.
Fig 2:
Imbert-Fick's principle which is used to calculate IOP. The cornea is neither a dry nor thin-walled sphere; multiple correction factors are used to calculate the IOP. The central corneal thickness is one factor that requires compensation. 
